{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:11:26Z","timestamp":1792642286033,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Fluoresc"],"DOI":"10.1007\/s10895-025-04520-7","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T01:25:41Z","timestamp":1755307541000},"page":"12609-12632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis, Spectroscopic, Electronic and Molecular Docking Studies of Pyrazole Based Chalcones as Potential Anticancer Agents"],"prefix":"10.1007","volume":"35","author":[{"given":"Noreen","family":"Aslam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afifa","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Arif","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansa Madeeha","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mussarat","family":"Jabeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbahul Ain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"issue":"7","key":"4520_CR1","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1021\/acsanm.1c00779","volume":"4","author":"S Bajpai","year":"2021","unstructured":"Bajpai S et al (2021) Recent advances in nanoparticle-based cancer treatment: a review. ACS Appl Nano Mater 4(7):6441\u20136470","journal-title":"ACS Appl Nano Mater"},{"issue":"6","key":"4520_CR2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1021\/acs.jproteome.4c00112","volume":"23","author":"R Lau","year":"2024","unstructured":"Lau R et al (2024) Secretome of cancer-associated fibroblasts (CAFs) influences drug sensitivity in cancer cells. J Proteome Res 23(6):2160\u20132168","journal-title":"J Proteome Res"},{"issue":"13","key":"4520_CR3","doi-asserted-by":"publisher","first-page":"8975","DOI":"10.1021\/acs.jmedchem.2c00190","volume":"65","author":"D Kanabar","year":"2022","unstructured":"Kanabar D et al (2022) Small-molecule Gankyrin inhibition as a therapeutic strategy for breast and lung cancer. J Med Chem 65(13):8975\u20138997","journal-title":"J Med Chem"},{"issue":"4","key":"4520_CR4","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/acs.molpharmaceut.3c01185","volume":"21","author":"VM Desai","year":"2024","unstructured":"Desai VM et al (2024) Photodynamic therapy induced mitochondrial targeting strategies for cancer treatment: emerging trends and insights. Mol Pharm 21(4):1591\u20131608","journal-title":"Mol Pharm"},{"issue":"1","key":"4520_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/jm0255825","volume":"46","author":"I Banik","year":"2003","unstructured":"Banik I, Becker FF, Banik BK (2003) Stereoselective synthesis of \u03b2-lactams with polyaromatic imines: entry to new and novel anticancer agents. J Med Chem 46(1):12\u201315","journal-title":"J Med Chem"},{"issue":"8","key":"4520_CR6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3109\/00498254.2012.754112","volume":"43","author":"D Maydt","year":"2013","unstructured":"Maydt D et al (2013) Chemical reactivity and biological activity of chalcones and other \u03b1, \u03b2-unsaturated carbonyl compounds. Xenobiotica 43(8):711\u2013718","journal-title":"Xenobiotica"},{"issue":"32","key":"4520_CR7","doi-asserted-by":"publisher","first-page":"27769","DOI":"10.1021\/acsomega.2c01779","volume":"7","author":"NA Elkanzi","year":"2022","unstructured":"Elkanzi NA et al (2022) Synthesis of chalcones derivatives and their biological activities: a review. ACS Omega 7(32):27769\u201327786","journal-title":"ACS Omega"},{"key":"4520_CR8","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","volume":"85","author":"P Singh","year":"2014","unstructured":"Singh P, Anand A, Kumar V (2014) Recent developments in biological activities of chalcones: a mini review. Eur J Med Chem 85:758\u2013777","journal-title":"Eur J Med Chem"},{"issue":"1","key":"4520_CR9","first-page":"19","volume":"8","author":"G Binate","year":"2023","unstructured":"Binate G, Ganbarov K (2023) Biological activity of Chalcones as carbonyl compound derivatives. Adv Biology Earth Sci 8(1):19\u201326","journal-title":"Adv Biology Earth Sci"},{"issue":"1","key":"4520_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11101-014-9387-8","volume":"15","author":"Z Rozmer","year":"2016","unstructured":"Rozmer Z, Perj\u00e9si P (2016) Naturally occurring chalcones and their biological activities. Phytochem Rev 15(1):87\u2013120","journal-title":"Phytochem Rev"},{"issue":"6","key":"4520_CR11","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.bmcl.2010.01.113","volume":"20","author":"M Bonesi","year":"2010","unstructured":"Bonesi M et al (2010) The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives. Bioorg Med Chem Lett 20(6):1990\u20131993","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"4520_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7324\/JAPS.2019.90816","volume":"9","author":"B Ardiansah","year":"2019","unstructured":"Ardiansah B (2019) Chalcones bearing N, O, and S-heterocycles: recent notes on their biological significances. J Appl Pharm Sci 9(8):117\u2013129","journal-title":"J Appl Pharm Sci"},{"issue":"22","key":"4520_CR13","doi-asserted-by":"publisher","first-page":"19194","DOI":"10.1021\/acsomega.3c01035","volume":"8","author":"K Mezgebe","year":"2023","unstructured":"Mezgebe K, Melaku Y, Mulugeta E (2023) Synthesis and pharmacological activities of chalcone and its derivatives bearing N-heterocyclic scaffolds: a review. ACS Omega 8(22):19194\u201319211","journal-title":"ACS Omega"},{"issue":"5","key":"4520_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00044-012-0193-9","volume":"22","author":"CGD Raj","year":"2013","unstructured":"Raj CGD et al (2013) In vitro biological activities of new heterocyclic chalcone derivatives. Med Chem Res 22(5):2079\u20132087","journal-title":"Med Chem Res"},{"issue":"8","key":"4520_CR15","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00044-012-0401-7","volume":"22","author":"P Sharma","year":"2013","unstructured":"Sharma P et al (2013) Synthesis and biologic activities of some novel heterocyclic chalcone derivatives. Med Chem Res 22(8):3969\u20133983","journal-title":"Med Chem Res"},{"issue":"1","key":"4520_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0975-7406.171694","volume":"8","author":"MJ Naim","year":"2016","unstructured":"Naim MJ et al (2016) Current status of pyrazole and its biological activities. J Pharm Bioallied Sci 8(1):2\u201317","journal-title":"J Pharm Bioallied Sci"},{"issue":"2","key":"4520_CR17","first-page":"831","volume":"32","author":"N Aslam","year":"2019","unstructured":"Aslam N et al (2019) Biologically active scaffolds: synthesis, characterization and studies of Oxino bis-pyrazoles by environmental friendly method. Pak J Pharm Sci 32(2):831\u2013837","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"4520_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1573407212666161101152735","volume":"14","author":"S Kumari","year":"2018","unstructured":"Kumari S, Paliwal SK, Chauhan R (2018) An improved protocol for the synthesis of chalcones containing pyrazole with potential antimicrobial and antioxidant activity. Curr Bioact Compd 14(1):39\u201347","journal-title":"Curr Bioact Compd"},{"issue":"1","key":"4520_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/14756366.2013.873037","volume":"30","author":"HV Chavan","year":"2015","unstructured":"Chavan HV et al (2015) Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones. J Enzyme Inhib Med Chem 30(1):22\u201331","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"8","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00044-019-02368-8","volume":"28","author":"AF Macarini","year":"2019","unstructured":"Macarini AF et al (2019) Pyrazole\u2013chalcone derivatives as selective COX-2 inhibitors: design, virtual screening, and in vitro analysis. Med Chem Res 28(8):1235\u20131245","journal-title":"Med Chem Res"},{"issue":"1","key":"4520_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/jhet.3380","volume":"56","author":"MH Ahmed","year":"2019","unstructured":"Ahmed MH et al (2019) Design, synthesis, and biological evaluation of novel pyrazole, oxazole, and pyridine derivatives as potential anticancer agents using mixed chalcone. J Heterocycl Chem 56(1):114\u2013123","journal-title":"J Heterocycl Chem"},{"issue":"11","key":"4520_CR22","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2174\/1871520623666230223112530","volume":"23","author":"J Yang","year":"2023","unstructured":"Yang J et al (2023) Recent progresses in chalcone derivatives as potential anticancer agents. Anticancer Agents Med Chem. 23(11):1265\u20131283","journal-title":"Anticancer Agents Med Chem."},{"issue":"3","key":"4520_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2174\/1871520610909030336","volume":"9","author":"S Ducki","year":"2009","unstructured":"Ducki S (2009) Antimitotic Chalcones and related compounds as inhibitors of tubulin assembly. Anticancer Agents Med Chem. 9(3):336\u2013347","journal-title":"Anticancer Agents Med Chem."},{"issue":"57","key":"4520_CR24","doi-asserted-by":"publisher","first-page":"46330","DOI":"10.1039\/C5RA02995C","volume":"5","author":"H-L Qin","year":"2015","unstructured":"Qin H-L et al (2015) Molecular docking studies and biological evaluation of chalcone based pyrazolines as tyrosinase inhibitors and potential anticancer agents. RSC Adv 5(57):46330\u201346338","journal-title":"RSC Adv"},{"key":"4520_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106171","volume":"129","author":"AH Ahmed","year":"2022","unstructured":"Ahmed AH et al (2022) Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of Lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities. Bioorg Chem 129:106171","journal-title":"Bioorg Chem"},{"key":"4520_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejmech.2017.02.002","volume":"129","author":"MM Hawash","year":"2017","unstructured":"Hawash MM et al (2017) Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics. Eur J Med Chem 129:12\u201326","journal-title":"Eur J Med Chem"},{"issue":"14","key":"4520_CR27","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1016\/j.bmc.2010.06.013","volume":"18","author":"B Insuasty","year":"2010","unstructured":"Insuasty B et al (2010) Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4, 5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg Med Chem 18(14):4965\u20134974","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"4520_CR28","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/s41598-022-07691-6","volume":"12","author":"N Maciejewska","year":"2022","unstructured":"Maciejewska N et al (2022) Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer. Sci Rep 12(1):3703","journal-title":"Sci Rep"},{"issue":"30","key":"4520_CR29","doi-asserted-by":"publisher","first-page":"21859","DOI":"10.1039\/D4RA03375B","volume":"14","author":"N Yasser","year":"2024","unstructured":"Yasser N et al (2024) Synthesis, anticancer evaluation of novel hybrid pyrazole-based chalcones, molecular docking, DNA fragmentation, and gene expression: in vitro studies. RSC Adv 14(30):21859\u201321873","journal-title":"RSC Adv"},{"key":"4520_CR30","volume-title":"Gaussian 16","author":"Me Frisch","year":"2016","unstructured":"Frisch Me et al (2016) Gaussian 16. Gaussian, Inc. Wallingford, CT"},{"key":"4520_CR31","first-page":"143","volume-title":"GaussView 6.0. 16","author":"R Dennington","year":"2016","unstructured":"Dennington R, Keith TA, Millam JM (2016) GaussView 6.0. 16. Semichem Inc., Shawnee Mission, KS, USA, pp 143\u2013150"},{"key":"4520_CR32","doi-asserted-by":"crossref","unstructured":"Zardecki C et al (2016) RCSB protein data bank: a resource for chemical, biochemical, and structural explorations of large and small biomolecules. ACS","DOI":"10.1021\/acs.jchemed.5b00404"},{"key":"4520_CR33","unstructured":"Gao Y-D, Huang J-F (2011) An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level."},{"issue":"2","key":"4520_CR34","first-page":"1","volume":"1","author":"N El-Gohary","year":"2014","unstructured":"El-Gohary N (2014) Arylidene derivatives as synthons in heterocyclic synthesis. Open Access Libr J 1(2):1\u201347","journal-title":"Open Access Libr J"},{"key":"4520_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.111963","volume":"207","author":"M Akhtar","year":"2024","unstructured":"Akhtar M et al (2024) Synthesis, characterization, and application of pyrene-based chalcones AIEgens for cellular and intracellular activity. Microchem J 207:111963","journal-title":"Microchem J"},{"issue":"8","key":"4520_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.7581","volume":"38","author":"S Iftikhar","year":"2024","unstructured":"Iftikhar S et al (2024) Synthetic route for O, S-coordinated organotin (IV) aldehydes: spectroscopic, computational, XRD, and antibacterial studies. Appl Organomet Chem 38(8):e7581","journal-title":"Appl Organomet Chem"},{"key":"4520_CR37","doi-asserted-by":"crossref","unstructured":"Hunter AD (1997) ACD\/ChemSketch 1.0 (freeware); acd\/chemsketch 2.0 and its tautomers, dictionary, and 3D plug-ins; ACD\/HNMR 2.0; ACD\/CNMR 2.0. ACS","DOI":"10.1021\/ed074p905"},{"key":"4520_CR38","doi-asserted-by":"publisher","first-page":"107742","DOI":"10.1016\/j.dyepig.2019.107742","volume":"171","author":"AM Arif","year":"2019","unstructured":"Arif AM et al (2019) Spectroscopic behavior, FMO, NLO and substitution effect of 2-(1H-Benzo [d] imidazole-2-ylthio)-No-substituted-acetamides: experimental and theoretical approach. Dyes Pigm 171:107742","journal-title":"Dyes Pigm"},{"key":"4520_CR39","doi-asserted-by":"crossref","unstructured":"Dallakyan S, Olson AJ (2014) Small-molecule library screening by Docking with PyRx, in Chemical Biology: methods and protocols. Springer, pp 243\u2013250","DOI":"10.1007\/978-1-4939-2269-7_19"},{"issue":"13","key":"4520_CR40","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF et al (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"},{"issue":"W1","key":"4520_CR41","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"4520_CR42","doi-asserted-by":"publisher","first-page":"12871","DOI":"10.1039\/D5CP01227A","volume":"27","author":"M Ibrahim","year":"2025","unstructured":"Ibrahim M et al (2025) Exploring the role of H-migration in the aromaticity, spectroscopic, photovoltaic and optical properties of planar heterocyclic compounds: a DFT study. Phys Chem Chem Phys 27(24):12871\u201312885","journal-title":"Phys Chem Chem Phys"},{"key":"4520_CR43","doi-asserted-by":"publisher","first-page":"125582","DOI":"10.1016\/j.saa.2024.125582","volume":"329","author":"A Yousuf","year":"2025","unstructured":"Yousuf A et al (2025) Spectroscopic studies and Non-Linear optical response through C\/N replacement and modulation of electron donor\/acceptor units on Naphthyridine derivatives. Spectrochim Acta Part A Mol Biomol Spectrosc 329:125582","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"4520_CR44","doi-asserted-by":"publisher","unstructured":"Khan FT (2025) Extrusion of carbon with SON in heterocycles for enhanced static and dynamic hyperpolarizabilities and light harvesting efficiencies. Chem Phys, p 596. https:\/\/doi.org\/10.1016\/j.chemphys.2025.112761","DOI":"10.1016\/j.chemphys.2025.112761"},{"issue":"6","key":"4520_CR45","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s11224-023-02150-y","volume":"34","author":"K Munny","year":"2023","unstructured":"Munny K et al (2023) Exploring the adsorption performance of doped graphene quantum dots as anticancer drug carriers for cisplatin by DFT, PCM, and COSMO approaches. Struct Chem 34(6):2089\u20132105","journal-title":"Struct Chem"},{"key":"4520_CR46","doi-asserted-by":"publisher","first-page":"102029","DOI":"10.1016\/j.rechem.2025.102029","volume":"13","author":"D Ali","year":"2025","unstructured":"Ali D et al (2025) Deciphering the role of flutamide, fluorouracil, and Furomollugin based ionic liquids in potent anticancer agents: quantum chemical, medicinal, molecular Docking and MD simulation studies. Results Chem 13:102029","journal-title":"Results Chem"},{"issue":"6","key":"4520_CR47","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1021\/jacsau.2c00085","volume":"2","author":"J Yu","year":"2022","unstructured":"Yu J, Su NQ, Yang W (2022) Describing chemical reactivity with frontier molecular orbitalets. JACS Au 2(6):1383\u20131394","journal-title":"JACS Au"},{"key":"4520_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.112492","volume":"301","author":"AM Arif","year":"2020","unstructured":"Arif AM et al (2020) N-(O-methoxyphenyl) aza-15-crown-5-ether derivatives: highly efficient and wide range nonlinear optical response based cation recognition. J Mol Liq 301:112492","journal-title":"J Mol Liq"},{"key":"4520_CR49","doi-asserted-by":"publisher","unstructured":"Ibrahim M, Khan FT, Yousuf A, Qureshi AM, Ali MA, Rauf A, Arshad M (2025) Unlocking the potential of Indolo-Carbazole derivatives: First-Principles insights into charge injection and optical switching applications. J Phys Chem Solids 113021. https:\/\/doi.org\/10.1016\/j.jpcs.2025.113021","DOI":"10.1016\/j.jpcs.2025.113021"},{"issue":"15","key":"4520_CR50","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.1158\/0008-5472.CAN-09-0301","volume":"69","author":"S Ali","year":"2009","unstructured":"Ali S et al (2009) The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Res 69(15):6208\u20136215","journal-title":"Cancer Res"},{"key":"4520_CR51","doi-asserted-by":"crossref","unstructured":"Sreenatha N et al (2024) Structure elucidation, DFT and IRI computational investigations of a novel 4-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl) 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarbonitrile. Journal of Molecular Structure, 1299: p. 137048","DOI":"10.1016\/j.molstruc.2023.137048"},{"key":"4520_CR52","doi-asserted-by":"publisher","first-page":"108173","DOI":"10.1016\/j.mssp.2024.108173","volume":"174","author":"SA Siddique","year":"2024","unstructured":"Siddique SA et al (2024) Discovery of pyrrole-triphenylamine based novel organic sensitizers for dye-sensitized solar cells: A first principal study. Mater Sci Semiconduct Process 174:108173","journal-title":"Mater Sci Semiconduct Process"},{"key":"4520_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2023.1279355","volume":"11","author":"A Hussain","year":"2023","unstructured":"Hussain A et al (2023) Exploration of violet-to-blue thermally activated delayed fluorescence emitters based on CH\/N and H\/CN substitutions at diphenylsulphone acceptor. A DFT study. Front Chem 11:1279355","journal-title":"Front Chem"},{"issue":"8","key":"4520_CR54","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1080\/10406638.2023.2261591","volume":"44","author":"JK Ojha","year":"2024","unstructured":"Ojha JK et al (2024) Structure, frontier molecular orbitals, MEP, charge analysis, and NLO study of 2, 4-, 2, 5-, and 2, 6-Dimethylanilines using DFT. Polycycl Aromat Compd 44(8):5166\u20135187","journal-title":"Polycycl Aromat Compd"},{"key":"4520_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137153","volume":"1299","author":"M Ayyaz","year":"2024","unstructured":"Ayyaz M et al (2024) Design, synthesis, in-vitro biological screening and in-silico studies of 2-thioxodihydropyrimidinone based new aminomethylene scaffolds. J Mol Struct 1299:137153","journal-title":"J Mol Struct"},{"issue":"18","key":"4520_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202405487","volume":"10","author":"R Zulfiqar","year":"2025","unstructured":"Zulfiqar R et al (2025) Design and prediction physicochemical properties of piperazinium and imidazolidinium based ionic liquids: a DFT and docking studies. ChemistrySelect 10(18):e202405487","journal-title":"ChemistrySelect"}],"container-title":["Journal of Fluorescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10895-025-04520-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:02:11Z","timestamp":1769778131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10895-025-04520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1007\/s10895-025-04520-7","relation":{},"ISSN":["1573-4994"],"issn-type":[{"value":"1573-4994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The author also declares there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}